Evidence map›Paper›PMID 34692241›Full record

ArticlePeerJ2021

Efficacy of krill oil versus fish oil on obesity-related parameters and lipid gene expression in rats: randomized controlled study.

Mevra Aydin Cil, Atena Ghosi Ghareaghaji, Yasin Bayir, Zehra Buyuktuncer, Halit Tanju Besler

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Mevra Aydin CilDepartment of Nutrition and Dietetics, Faculty of Health Sciences, Hacettepe University, Ankara, Turkey.
Atena Ghosi GhareaghajiDepartment of Molecular Biology and Genetics, Faculty of Science, Atatürk University, Erzurum, Turkey.
Yasin BayirDepartment of Biochemistry, Faculty of Pharmacy, Atatürk University, Erzurum, Turkey.
Zehra BuyuktuncerDepartment of Nutrition and Dietetics, Faculty of Health Sciences, Hacettepe University, Ankara, Turkey.
Halit Tanju BeslerDepartment of Nutrition and Dietetics, Faculty of Health Sciences, Hacettepe University, Ankara, Turkey.
Atatürk University · TRHacettepe University · TRIstinye University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backroundThis study aimed to determine the effects of LC n-3 PUFA supplementation on the prevention and treatment of obesity and obesity-related diseases, and to compare the efficiency of different LC n-3 PUFA sources via biochemical and genetic mechanisms in rats.

methodsMale Wistar rats were randomized into four study groups, and fed with a standard diet, High Fat Diet (HFD), HFD+%2.5 Fish Oil (FO-HFD) or HFD+%2.5 Krill Oil (KO-HFD) for eight weeks. Food consumption, weight gain, serum glucose, insulin, ghrelin and leptin concentrations, lipid profile, liver fatty acid composition, and FADS1 and FADS2 mRNA gene expression levels were measured.

resultsWeight gain in each HFD group was significantly higher than control group (

conclusionLC n-3 PUFAs, especially krill oil, had moderate effects on lipid profile, but limited effects on obesity related parameters, suggesting different effects of different sources on gene expression levels. Further randomized controlled trials are needed to determine the efficacy of different LC n-3 PUFA sources in the prevention and treatment of obesity in humans.

Indexed as

Fatty acid desaturaseFish oilGene expressionKrill oilLC n-3 PUFAObesity

Identifiers

PMID34692241
PMCPMC8483003
OpenAlexW3202844297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.